Sarepta Leapfrogs Pfizer In The US, Launching DMD Gene Therapy Pivotal Trial

 
• By Jessica Merrill
  
green light
Sarepta has initiated its pivotal DMD gene therapy trial • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies